Oxalate nitrate

Add links
Source: Wikipedia, the free encyclopedia.

An oxalate nitrate is a chemical compound or salt that contains

mixed anion compounds
. Some have third anions. Oxalate acts as a ligand, which normally complexes two metal atoms.

Naming

An oxalate nitrate compound may also be called a nitrate oxalate. In chemical formulae, oxalate may be indicated by "ox". As a ligand oxalate is termed "oxalato", and nitrate, "nitrato".

Production

Most oxalate nitrates are formed by crystallisation from water solutions. One issue is the insolubility of metal oxalates.

Properties

On heating, oxalate nitrates lose NO2, NO, CO, and CO2 and form metal carbonates or oxides.

Related

Related to these are the oxalate phosphates and oxalate perchlorates.

List

name formula ratio

C2O4:NO3

mw
 system space group unit cell Å volume density properties references
phen = 1,10-phenanthroline [Cr(phen)2(C2O4)]NO3·H2C2O4·H2O monoclinic Cc a=15.856 b=14.353 c=13.141 β=106.517° Z=4 2867 1.553 orange [1]
bpy = 2,2′-bipyridine [Cr(bpy)2(C2O4)]NO3·1/2H2C2O4·4H2O monoclinic P21/c a=10.5565 b=17.1770 c=14.8525 β=99.272° Z=4 2658.00 1.578 orange [1]
fac-triammin-aquo-oxalato-cobalt(III)-nitrate monohydrate, fac-[Co(NH3)3(C2O4)(H2O)]NO3·H2O monoclinic P21/n a=7.853 b=10.000 c=13.192 β=105.06° [2]
[Co(NH3)4(C2O4)]NO3·H2O P212121 a=7.944 b=9.90 c=12.700 Z=4 999.15 1.968
Oxalato di(1,10-phenanthroline-N,N′) cobalt(III) nitrate 3.88 hydrate [Co(C12H8N2)2(C2O4)]NO3·3.88H2O 639.14 orthorhombic Ibca a = 15.492 b = 17.938 c = 19.635 Z = 8 5457 1.556 pink [3]
ept = N-(2-aminoethyl)-1,3-diaminopropane [(Ni(ept)H2O)2ox](NO3)2 [4]
Ni2en4(C2O4)(NO3)2 [5]
bpy = 2,2′-bipyridine [{Ni(bpy)2}2(μ-C2O4)](NO3)2·H2C2O4 1044.23 triclinic P1 a 9.2921 b 12.8702 c 18.9812 α 84.660° β 75.969° γ 85.056° Z=2 2187.9 1.585 violet [6]
m-xpt = bis(pyridyltriazole) ligand [Ni2(m-xpt)2(C2O4)](NO3)2 [7]
dien = diethylenetriamine (H3dien)[Ni(NO3)(C2O4)2].2H2O monoclinic P21/c a=10.218 b=11.074 c=14.897 β=103.988° blue [8]
bpt = pyridyltriazole ligand Cu2(bpt)2(NO3)2(DMF)2(C2O4) [7]
[(Cu(ept))2ox](NO3)2·H2O [4]
Diethylenetriammonium nitrato-bis(oxalato)cuprate (II) dihydrate (H3dien)[Cu(NO3)(C2O4)2].2H2O monoclinic P21/c a = 10.1054 b = 11.0825 c = 14.8238 β = 103.516° Z = 4 1614.2 [9]
dien=diethylenetriamine [Cu2(C2O4)(dien)2](NO3)3 monoclinic P2/c a = 23.7888(10), b = 6.7055(3), c = 12.7842(6) and β = 95.534 [10]
Sparteine copper(II) nitrate oxalate Cu2(C15H26N2)2(NO3)2(C2O4) 1:2 light green [11]
di-2-pyridylamine Cu2(dpyam)2(μ-C2O4)(NO3)2(DMF)2 triclinic P1 a=8.353 b=9.100 c=12.245 α=72.035° β=75.228° γ=78.552° [12]
(μ2-oxalato)-bis(di-2-pyridylamine)-bis(N,N',-dimethylformamide)-di-copper(ii) iodide nitrate [Cu2(dpyam)2(μ-C2O4)(DMF)2](I)1.6(NO3)0.4 triclinic P1 a=8.4616 b=8.9112 c=12.3824 α=71.913° β=76.329° γ=80.225° [13]
Cu2(dpyam)2(C2O4)(NO3)2((CH3)2SO)2] [14]
Cu2(bpy)2(C2O4)(NO3)2(H2O)2 [14]
meprizole=(4-methoxy-2-(5-methoxy-3-methylo-pyrazol-1-yl)-6-methylpyrmadine) [Cu2(mepirizole)2(C2O4)(NO3)2(H2O)]2[Cu2(mepirizole)2(C2O4)(NO3)2] monoclinic P21/c a=20.073 b=13.842 c=11.451 β=119.09° Z=4 [15]
Cu2(histamine)2(C2O4)(H2O)2(NO3)2 triclinic P1 a=7.579 b=8.133 c=9.161 α=77.06° β=89.23° γ=82.54° Z=1 545.6 [16]
[Cu2(bpy)2(C2O4)(H2O)2][Cu(bpy)(C2O4)](NO3)2 [17]
trimeen = N,N,N'-trimethylethylenediamine [(Cu(trimeen)H2O)2ox](NO3)2 ·2H2O [18]
Pz2CPh2 = diphenyldipyrazolylmethane Cu2(Pz2CPh2)2(NO3)2(μ-C2O4) triclinic P1 a = 8.863 b = 10.241 c = 11.43 α = 98.98° β = 110.45° γ = 103.66° Z=2 [19]
Pz3m2CPh2 = diphenylbis(3-methylpyrazolyl)methane [Cu2(Pz3m2CPh2)2(H2O)2(μ-C2O4)](NO3)2·H2O monoclinic C2/c a = 23.459 b = 8.8568 c = 21.782 β = 100.889° Z=4 [19]
phen = 1,10-phenanthroline; (μ2-Oxalato-O,O',O'',O''')-diaqua-bis(1,10-phenanthroline)-di-copper(ii) dinitrate [Cu2(ox)(phen)2(H2O)2](NO3)2 monoclinic P21/n a=7.128 b=11.715 c=16.529 β=91.80° [20]
4,4’-bipyridine; 1,10-phenanthroline; [Cu2(ox)(4,4’-bpy)(phen)2](NO3)2 855.72 monoclinic C2/c a=23.144 b=10.6601 c=13.4363 β=93.123° Z=4 3310.4 green [21]
Bipy = 2,2′-bipyridine; Cu2(Bipy)2(H2O)2(C2O4)(NO3)2 [22]
μ-oxalato-κ4O1,O2:O1′,O2′-bis(aqua(nitrato-κO){[1-(2-pyridyl-κN)ethylidene]hydrazine-κN}copper(II)) μ-oxalato-κ4O1,O2:O1′,O2′-bis((methanol-κO)(nitrato-κO){[1-(2-pyridyl-κN)ethylidene]hydrazine-κN}copper(II)) [Cu2(C2O4)(NO3)2(C7H9N3)2(H2O)2][Cu2(C2O4)(NO3)2(C7H9N3)2(CH4O)2] triclinic P1 a = 9.8358 b = 12.377 c = 12.714 α = 103.704° β = 112.573° γ = 107.821° Z = 1 1245.15 [23]
(μ2-oxalato)-bis(dimethylsulfoxido)-bis(di-2-pyridylamine)-dinitrato-di-copper(ii) [Cu2(dpyam)2(C2O4)(NO3)2((CH3)2SO)2 triclinic P1 a 8.7190 b 8.9680 c 11.421 α 68.58° β 77.79° γ 80.58° [24]
(μ2-Oxalato-O,O',O'',O''')-diaqua-bis(2,3-bis(2-pyridyl)pyrazine)-di-copper(ii) dinitrate tetrahydrate [Cu2(dpp)2(H2O)2(NO3)2(ox)]·4H2O monoclinic P21/c a=9.704b=7.2598 c=25.865 β=97.395° [25]
L=4,4′-methylenebis(1-(2-pyridyl)-3,5-dimethylpyrazole;

(μ2-4,4'-Methylenebis(1-(2-pyridyl)-3,5-dimethylpyrazole))-bis(nitrato-O)-di-copper acetonitrile solvate

CuL(C2O4)(NO3) monoclinic P2/n a=8.5679 b=9.3862 c=20.5910 β=101.038° [26]
bis(μ2-oxalato)-tetrakis(2,2'-bipyridine)-(oxalato)-di-copper(ii)-chromium(iii) nitrate monohydrate [{Cu(μ-C2O4)(bpy)2}2Cr(C2O4)]NO3·H2O monoclinic C2/c a=6.428 b=17.162 c=16.749 β=110.721° [27]
bis(tris(2,2'-bipyridine)-copper(ii)) tris(oxalato)-chromium(iii) nitrate nonahydrate [Cu(bpy)3]2[Cr(C2O4)3]NO3·9H2O monoclinic P21/c a=31.314 b=13.536 c=22.202 β=132.01° [27]
(μ2-Oxalato)-tetrakis(μ2-N,N'-propane-1,3-bis(3-methoxysalicylideneiminato))-diaqua-bis(nitrato-O)-tetra-copper(ii)-di-neodymium(iii) dinitrate hexahydrate [{(LCuII(ONO2))(LCuII(H2O))NdIII}2(μ-C2O4)](NO3)2 · 6H2O monoclinic P21 a=16.982 b=15.241 c=17.368 β=96.71° [28]
(H3O,N2H5)5{[Ce(H2O)][Ce(NO3)]2(C2O4)6}.6H2O tetragonal P43212 a=11.6521 c=27.9597 [29]
(H3O,N2H5)2{Nd(C2O4)2NO3} monoclinic P21/c a=9.296 b=17.214 c=9.214 β=116.586 [29]
(H3O,N2H5)2(NO3)2{Eu2(H2O)6(C2O4)3} monoclinic P21/n a=8.0806 b=18.986 c=17.318 β=99.331° [29]
melaminium [C3H7N6]6[Dy(C2O4)4][NO3] triclinic P1 a=9.777 b=10.676 c=25.083 α=97.18° β=79.81° γ=86.52° 2570 [30]
melaminium [C3H7N6]6[Ho(C2O4)4][NO3] triclinic P1 a=9.760 b=10.660 c=25.051 α=87.24° β=87.24° γ=79.96° 2559 [30]
(N2H5){Er(C2O4)2}.2H2O tetragonal P43212 a=11.3348 c=9.2646
melaminium [C3H7N6]6[Yb(C2O4)4][NO3] triclinic P1 a=9.7297 b=10.5937 c=24.9904 α=87.271° β=80.123° γ=86.955° 2532.15 [30]
lead nitrate oxalate Pb2(NO3)2(C2O4)⋅2H2O monoclinic P21/c a=10.623 b=7.9559 c=6.1932 β=104.49° Z=4 [31][32]
(OPb2)2(C2O4)(NO3)2 monoclinic P21/c a=11.8682 b=5.2501 c=9.0989 β=96.741° [33]
μ-Oxalato-κ4O1,O2:O1′,O2′-bis[aqua(2,2′-bipyridine-κN)(nitrato-κ2O,O′)lead(II)] Pb2(C2O4)(NO3)2(C10H8N2)2(H2O)2 monoclinic P21/c a=9.579 b=20.633 c=6.765 β=91.687° Z=2 1336.5 [34]
bipy = 2,2′-bipyridine; (μ2-oxalato)-bis(2,2'-bipyridine)-dinitrato-diaqua-di-lead Pb2(ox)(bipy)2(NO3)2(H2O)2 monoclinic P21/c a=9.5444 b=20.5956 c=6.7449 β=91.819° [35]
phen = 1,10-phenanthroline {Pb(phen)2}2Cr(ox)2(phen)][Cr(ox)2(phen)](NO3)2 triclinic P1 a 13.311 b 18.861 c 19.500 α 115.14° β 107.54° γ 96.28° [36]
AgPb(C2O4)(NO3) heat decompose to Ag and PbCO3 [37]
tetraethyldiglycolamide [Th(TEDGA)2(C2O4)][NO3]2[H2C2O4].6H2O 1128.86 tetragonal P42212 a=18.714 c=12.9212 Z=4 4525.2 1.657 @100K Th is 10 coordinate [38]
tetraethyldiglycolamide [Th2(C2O4)3(TEDGA)4][NO3][HC2O4][H2C2O4]4.7H2O 2340.47 triclinic P1 a=15.6611 b=17.9082 c=18.1814 α=89.896° β=65.549° γ=87.623° Z=2 4637.2 1.676 @100K is 10 coordinate, bicapped square antiprism [38]
diammonium oxalatotetranitratouranylate (NH4)2[{UO2(NO3)2}2(μ4-C2O4)] · 2H2O 1:4 monoclinic P21/c a = 8.650 b = 11.700 c = 20.213 β = 93.92° Z = 4 2040.9 [39]
Aqua-(2,2'-bipyridine)-bis(nitrato)-(μ2-oxalato)-dioxo-uranium(vi)-copper(ii) UO2Cu(C2O4)(NO3)2(bipy)(H2O) triclinic P1 a 7.7582 b 11.0274 c 12.181 α 66.717° β 85.541° γ 87.653° [40]
(μ2-2,2'-bipyrimidine)-bis(μ2-oxalato)-bis(μ2-hydroxo)-tetraoxo-bis(nitrato)-di-copper-di-uranium [(UO2)2Cu2(C2O4)2(bipym)3(OH)2]·2NO3 triclinic P1 a 9.9169 b 10.9294 c 11.1783 α 103.449° β 110.754° γ 110.069° [40]
[C6H14N]4[UO2(C2O4)2(HC2O4)]NO3·2H2O 1033.86 monoclinic P21/c a=11.9358 b=18.7279 c=19.1956 β=102.210° Z=4 4193.8 1.637 [41]
[C8H18N][UO2(C2O4)(NO3)] monoclinic P21/c a=11.3688 b=11.0238 c=13.4478 β=11.465° Z=4 1557.5 2.338 [41]

References

  1. ^
    PMID 23103949
    .
  2. ISSN 2073-4352
    .
  3. ISSN 1348-2238
    .
  4. ^
    ISSN 0010-0765
    .
  5. ISSN 0022-4944
    .
  6. ISSN 1466-8033
    .
  7. ^
    doi:10.31390/gradschool_dissertations.5353
    .
  8. S2CID 253473558
    .
  9. S2CID 259266416
    .
  10. S2CID 257264452
    .
  11. doi:10.5012/BKCS.2002.23.3.404
    .
  12. S2CID 97352070
    .
  13. doi:10.1016/j.mencom.2010.03.015
    .
  14. ^
    ISSN 0253-2964
    .
  15. ISSN 0020-1669
    .
  16. doi:10.1006/jssc.2000.8682
    .
  17. doi:10.1016/0277-5387(96)00244-6
    .
  18. S2CID 98024533
    .
  19. ^
    PMID 15998034
    .
  20. doi:10.1016/j.ica.2006.12.041
    .
  21. ISSN 0253-2964
    .
  22. S2CID 207912853
    .
  23. PMID 21201585
    .
  24. doi:10.1016/S0020-1693(03)00207-X
    .
  25. ISSN 1434-1948
    .
  26. ISSN 0004-9425
    .
  27. ^
    ISSN 1434-1948
    .
  28. doi:10.1016/j.ica.2007.05.018
    .
  29. ^
    ISSN 0272-9172
    .
  30. ^
    ISSN 0044-2313
    .
  31. S2CID 98700786
    .
  32. doi:10.1016/S1293-2558(01)01188-8
    .
  33. doi:10.1016/j.jssc.2008.02.021
    .
  34. PMID 23125622
    .
  35. doi:10.1016/j.ica.2013.10.001
    .
  36. S2CID 250080604
    .
  37. ISSN 1144-0546
    .
  38. ^ a b Farger, P.; Haidon, B.; Roussel, P.; Arab-Chapelet, B.; Rivenet, M. (2018). "Single-Crystal to Single-Crystal Transformation in the Thorium-TEDGA-Oxalate-Nitrate System Description and Comparison of the Main Structural Features". Unknown.
  39. S2CID 98853037
    .
  40. ^
    PMID 23760346
    .
  41. ^
    ISSN 1674-7224
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=Oxalate_nitrate&oldid=1211962108"